Low-density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension

Hypertension

Volumn 31, Issue 2, 1998, Pages 621-626

  Pierdomenico, Sante D ^a,b   Costantini, Fabrizio ^a   Bucci, Anna ^a   De Cesare, Domenico ^a   Cuccurullo, Franco ^a   Mezzetti, Andrea ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Istituto di Patologia Medica   (Italy)

Author keywords

Hypertension, white coat; LDL; Oxidation; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL; PROTEIN ISOLATION;

EID: 0031911262     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.2.621     Document Type: Article

References (62)

1. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, LaraghJH. How common is white-coat hypertension? JAMA. 1988;259:225-228.
2. Pierdomenico SD, Mezzetti A, Lapenna D, Guglielmi MD, Mancini M, Salvatore L, Antidormi T, Costantini F, Cuccurullo F. White-coat hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heurt J. 1995;16:692-697.
3. White WB, Schulman P, MacCabe FJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. AAH. 19S9;261:873-877.
4. Julius S, Mejia A, Jones K, Krause L, Schork N, van de Ven C, Johnson E, Pétrin J, Sekkarie A, Kjeldsen SE, Schmouder R, Gupta R, Ferraro J, Nazzaro P, WeissfeldJ. White-coat versus sustained borderline hypertension in Tecumseh, Michigan. Hypertension. 1990;16:617-623.
5. Hoegholm A, Kristensen KS, Bang LE, NielsenJW, Nielsen WB, Madsen NH. Left ventricular mass and geometry in patients with established hypertension and white-coat hypertension. AmJ Hypcrtcns. 1993;6:282-286.
6. Gosse P, Promax H, Durandet P, ClementyJ. White-coat hypertension. No harm for the heart. Hypotension. 1993;22:766-770.
7. Cardillo C, De Felice F, Campia U, Folli G. Psychophysiological reactivity and cardiac end-organ changes in white-coat hypertension. Hypertension. 1993;21:836-844.
8. Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white-coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension. 1993;22:826-831.
9. Weber MA, Neutel JM, Smith DHG, Graettinger WF. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation. 1994; 90:2291-2298.
10. Marches! E, Perani G, Falaschi F, Negro C, Catalano O, Ravetta V, Finardi G. Metabolic risk factors in white-coat hypertensives. J Hum Hypcrtens. 1994;8:475-479.
11. Hoegholm A, Bang LE, Kristensen KS, Nielsen J W, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white-coat hypertension, and normotension. Hypertension. 1994;24: 101-105.
12. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
13. Cavallini MC, Roman MJ, Pickering TG, Schwanz JE, Fini R, Devereux RB. Is white-coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension. 1995;26:413-419.
14. Pierdomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccurullo F, Mezzetti A. Target organ status and serum lipids in patients with white-coat hypertension. Hypertension. 1995;26:801-807.
15. Nakazono K, Watanabe N, Matsuno K, SasakiJ, Sato T, Inoue M. Does Superoxide underlie the pathogenesis of hypertension ? Proc Natl Acad Sei USA. 1991;88:10045-10048.
16. Sagar S, Kallo JI, Kaul N, Granguly NK, Sharma BK. Oxygen free radicals in essential hypertension. Mol Cell Biodicm. 1992;! 11:103-108.
17. Shanria RC, Crawford DW, Kramsch DM, Sevanian A, Jiao Q. Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries: role of oxygen free radicals. Artcriosdcr Tliromb. 1992;12:403-415.
18. Jameson M, Dai FX, Lusher T, Skopec J, Diederich A, Diederich D. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. Hypertension. 1993;21:280-288.
19. Kumar KW, Das UM. Are free radicals involved in the pathobiology of human essential hypertension? Free Radie Res Commun. 1993:19:59-66.
20. De Bruyn VH, Nuno DW, Cappelli-Bigazzi M, Dole WP, Lamping KG. Effect of acute hypertension in coronary circulation: role of mechanical factors and oxygen radicals.J Hypertens. 1994;12:163-172.
21. Alexander RW. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response-a new perspective. Hypertension. 1995;25:155-161.
22. Cuccurullo F, Porreca E, Lapenna D, Pennelli A, Savini F, Mezzetti A, Marzio L, Ricci G, Del Boccio G. Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension. J AM Cell Cardiol. 1991;23:727-734.
23. Chobanian AV, Alexander RW. Exacerbation of atherosclerosis by hypertension: potential mechanisms and clinical implications. Arch Intern \led. 1996;156:1952-1956.
24. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, WitztumJL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. A.' EiylJ Med. 1989;320:915-924.
25. Salonen JT, Yla-Herttuala S, Yamamoto R, Buder S, Korpela H, Salonen R, Nyyssonen K, Palinski \V, Witztum J. Autoantiboby against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992:339:883-887.
26. Kugiyama K, Kerns SA, Morrisset JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lisolecithin in modified low-density lipoprotein. Nature. 1990;344:160-162.
27. Simon BC, Cunningham LD, Cohen RA. Oxidised low-density lipoprotein cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
28. Galle J, Bassenge E, Busse R. Oxidised low-density lipoprotein potentiate vasoconstriction to various agonists by direct interaction with vascular smooth muscle. Grc Res. 1990;66:1287-1293.
29. Galle J, Ochslen M, Schollmeyer P, Wanner C. Oxidized lipoproteins inhibit endothelium-dependent vasodilation: effects of pressure and highdensity lipoprotein. Hypertension. 1994;23:556-564.
30. Maggi E, Marchesi E, Ravetta V, Falaschi F, Finardi G, Bellomo G. Low-density lipoprotein oxidation in essential hypertension. J Hypcrtcns. 1993:11:1103-1111.
31. Maggi E, Marchesi E, Ravetta V, Martignoni A, Finardi G, Bellomo G. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J Hypcrtcns. 1995;13: 129-138.
32. Keidar S, Kaplan M, Shapira C, Brook JG, Aviram M. Low-density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis. 1994;107:71-84.
33. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Katl Acad Sei USA. 1989;86:6377-6381.
34. Esterbauer H, GebickiJ, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radie Biol Meet. 1992;13:341-390.
35. Pickering TG. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. AmJ Hypcrtcns. 1996;9:1-11.
36. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, ConeJT. Single vertical spin density gradient ultracentrifugation. Methods Enzymol. 1986:128:181-209.
37. Lynch SM, Frei B. Mechanisms of copper- and iron-dependent oxidative modification of human low-density lipoprotein. J Lipid Res. 1993;34: 1745-1753.
38. Lowry OH, Rosenbrough MJ, Farr AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Diol Chem. 1951;193:265-275.
39. Esterbauer H, Stiegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radie Res Commun. 1989;6:67-75.
40. Dillard CJ, Tappel AL. Fluorescent damage products of lipid peroxidation. Methods Enzymol. 1984:105:337-348.
41. Kikugawa K. Fluorescent products derived from the reaction of primary amines and components in peroxidized lipids. Adv Free Radie Biol Med. 1986:2:389-417.
42. Steinbrecher UP. Oxidation of human low-density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem. 1987;262:3603-3608.
43. Cominacini L, Garbin U, Davoli A, Micciolo R, Bosello O, Gaviraghi G, Scuro LA, Pastorino AM. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res. 1991;32:349-358.
44. Fukuda F, Kitada M, Hone T, Awazu S. Evaluation of adriamycin-induced lipid peroxidation. Biochem Phannjcol. 1992;44:755-760.
45. Kagan VE, Serbinova EA, Forte T, Scita G, Packer L. Recycling of vitamin E in human low-density lipoproteins. J Lipid Res. 1992:33:385-397.
46. Lee BL, Chua SC, Ong HY, Ong CN. High-performance liquid chromatographic method for routine determination of vitamins A and E and /3-carotene in plasma. Chromatogr. 1992:581:41-47.
47. Mezzetti A, Lapenna D, Pierdomenico SD, Calafiore AM, Costantini F, Riario-Sforza G, Imbastaro T, Neri M, Cuccurullo F. Vitamins E, C, and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atlierosclerosis. 1995:112:91-99.
48. Airman DG. Practical Statistics for Medical Research. London, UK: Chapman and Hall; 1992:179-276.
49. Avogaro P, Bittolo-Bon G, Cazzolato G. Presence of modified low-density lipoprotein in humans. Arteriosclerosis. 1988;8:79-87.
50. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendricks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low-density lipoprotein subfraction in healthy subjects. Arteriosder Tliromb. 1991;11:298-306.
51. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, Khoo JC, Steinberg D, Witztum JL. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am] Clin Kutr. 1991:54:701-706.
52. Bonanome A, Pagnan A, Biffanti S, Opportuno A, Sorgato F, Dorella M, Maiorino M, Ursini F. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low-density lipoproteins to oxidarive modifications. Artcrioscler Tliromb. 1992;12:529-533.
53. Abbey M, Belling GB, Noakes M, Hirata F, Nestel PJ. Oxidation of low-density lipoproteins: intraindividual variability and effect of dietary linoleate supplementation. Am J Clin Nutr. 1993;57:391-398.
54. Suzukawa M, Abbey M, Howe PRC, Nestel PJ. Effects of fish ou fatty acids on low-density lipoprotein size, oxidizability, and uptake by macrophages. J Lipii Res. 1995:36:473-484.
55. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low-density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992;93:189-199.
56. Wen Y, Killalea S, McGettigan P, Leely J. Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients. IrJMed Sei. 1996;165: 210-212.
57. Yoshioka M, Matsushita T, Chuman Y. Inverse association of serum . ascorbic acid level and blood pressure or rate of hypertension in male adults aged 30-39 years. IntJ Vit h'ulr Res. 198-t;54:343-347.
58. SalonenJT, Salonen R, Ihanainen M, Parviainen M, Seppanen R, Kontola M, Seppanen K, Rauramaa R. Blood pressure, dietary fats and antioxidants. Am] Oin Nutr. 1988;48:1226-1232.
59. MoranJP, Cohen L, Greene JM, Xu G, Feldman EB, Harnes CG, Feldman DS. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nitr. 1993;57:213-217.
60. Ness AR, Khaw KT, Bingham S, Day NE. Vitamin C status and blood pressure. J Hypcrtens. 1996;14:503-508.
61. Verdecchia P, Borgioni C, Ciucci A, Gattobigio R, Schillaci G, Sacchi N, Santucci A, Santucci C, Reboldi G, Porcellati C. Prognostic significance of blood pressure variability in essential hypertension. Blood Pressure Monitoring. 1996;1:3-11.
62. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. Prognostic significance of the white-coat effect. Hypotension. 1997;29:1218-1224.